Business Development

Our business strategy is to do what we do best — develop our ZFP technology through research, preclinical and early stage clinical testing. We then look for partners to help us fully realize the value of certain programs through late stage clinical trials and commercialization.

Partnering

We currently own all of our ZFP Therapeutic programs. However, we plan to partner certain programs at points of value inflection. (Note: In October 2011, we announced that we will complete follow up on the SB-509 Phase 2b trial but discontinue any further development of the drug.)

For information about:
Existing Partnerships
Research Collaborations